Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01215513
What this trial is testing

Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 127
Not applicableStudy completedNCT01813097
What this trial is testing

Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese PLA General Hospital 60
Early research (Phase 1)Study completedNCT00502164
What this trial is testing

Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Adenocarcinoma
AstraZeneca 40
Testing effectiveness (Phase 2)UnknownNCT00348998
What this trial is testing

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Virginia Mason Hospital/Medical Center 18
Not applicableEnded earlyNCT03553732
What this trial is testing

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

Who this might be right for
Prostatic Neoplasms
University of California, San Francisco 48
Not applicableActive Not RecruitingNCT06523777
What this trial is testing

PRISM: Patient Experiences With PET Imaging in Prostate Cancer

Who this might be right for
Prostate Cancer
Yale University 350
Not applicableStudy completedNCT05764330
What this trial is testing

Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance

Who this might be right for
Prostate Carcinoma
Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Not applicableEnded earlyNCT02131207
What this trial is testing

MRI Before Biopsy in Diagnosing Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 139
Not applicableStudy completedNCT02618200
What this trial is testing

Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 2
Large-scale testing (Phase 3)Active Not RecruitingNCT03531099
What this trial is testing

Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 108
Testing effectiveness (Phase 2)Study completedNCT00108732
What this trial is testing

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

Who this might be right for
Recurrent Prostate CarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04493853
What this trial is testing

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Who this might be right for
Hormone-Sensitive Prostate Cancer
AstraZeneca 1,012
Early research (Phase 1)Study completedNCT00868595
What this trial is testing

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate Cancer (CRPC)
Bellicum Pharmaceuticals 18
Not applicableUnknownNCT06677775
What this trial is testing

Pathological Positivity Rate in Prostate Cancer Patients with PI-RADS 4 and First Negative Biopsy

Who this might be right for
Prostate Cancer
Anhui Provincial Hospital 30
Not applicableStudy completedNCT00002981
What this trial is testing

PET Scan in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 173
Not applicableLooking for participantsNCT00913939
What this trial is testing

High-Dose-Rate Brachytherapy

Who this might be right for
Patients With Prostate Cancer
University Health Network, Toronto 500
Testing effectiveness (Phase 2)Study completedNCT05478239
What this trial is testing

ArtemiCoffee in Patients With Rising PSA

Who this might be right for
Prostate Cancer
Zin W Myint 20
Large-scale testing (Phase 3)Study completedNCT04534075
What this trial is testing

Dietary Fiber During Radiotherapy - a Placebo-controlled Randomized Trial

Who this might be right for
Malignant NeoplasmMalignant Neoplasm of RectumMalignant Neoplasm of Anus+7 more
Sahlgrenska University Hospital 354
Not applicableStudy completedNCT02140502
What this trial is testing

Incidence of Fluoroquinolone Resistant Bacteria in Patients Undergoing Prostate Biopsy

Who this might be right for
Fluoroquinolone Resistant Enteric Bacteria
Helsinki University Central Hospital 200
Next Page